• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Invitae | Genelex

Invitae | Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • For Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
  • For Providers
    • Conditions
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • Contact Us
  • Log In

How Many Deaths Will it Take?

Home / Data / How Many Deaths Will it Take?

Genelex Blog

How Many Deaths Will it Take?

Is death an inevitable side effect? I read an article recently by Dr. Mrazek at the Mayo Clinic entitled “How Many Deaths Will it Take.” The article pointed out the number of deaths from adverse drug reactions and that widespread adoption of pharmacogenetic testing would reduce this number. Yesterday, Dr. Mrazek’s statement came closer to home. I received an e-mail from Roman Finnegan. Roman and has family have not only endured the death of their young daughter by warfarin overdose, but have been battling CPS and the courts to drop false charges of child abuse because of the bruising and bleeding the overdose lead to. The case was finally dismissed earlier this month. You can view the statements that lead to the dismissal at the links below.

Affidavit of Edith Nutescu  - Director of the Antithrombosis Center, a member of the Affiliate Faculty at the Center for Pharmacoeconomic Research, and a Clinical Associate Professor in the Department of Pharmacy Practice at the College of Pharmacy, University of Illinois at Chicago.   Declaration of Bruce Lambert  – Department of Pharmacy Administrator and Clinical Professor, Department of Pharmacy Practice, University of Illinois at Chicago. Roman closed his e-mail by stating "I think your company should use this case as an example. It's one thing to say your product can save lives. It's another to demonstrate how it can help to avoid a tragedy like the one we have endured.”

Granted warfarin protocols were not adhered to as they should have been in this case, but a simple DNA test could have determined a more accurate dose from the beginning of therapy. Without the CYP 2C9 and VKORC1 genotypes, physician’s are prescribing with huge gaps in the information available to them, as shown in the pie chart below.

Would you prescribe without knowing the age, weight and gender of your patient?
Why proceed without the genetic component?

Genelex Resources

Affected Conditions
Affected Drugs
Info for Providers
Frequently Asked Questions
Contact Genelex
Join Our Mailing List

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
FAQs
References

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Contact Us
Privacy Practices
Privacy Policy

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.